Cagrilintide, also identified by the research designations AM-833 and NN0174-0833, is a synthetic, lipidated peptide analogue that has been investigated in scientific and pharmacological research. PubChem identifies cagrilintide under CAS 1415456-99-3.
This product is presented strictly as a research material for qualified laboratory and scientific applications.
Product Classification
Primary Category: Research Peptides
Scientific Category: Long-Acting Amylin Analogue
Secondary Category: Peptide Research Compounds
Product Type: Research Material
Catalog Tags
Cagrilintide · AM-833 · Amylin Analogue · Research Peptide · Synthetic Peptide · Laboratory Research · Research Material
Chemical Information
Compound: Cagrilintide
Alternative Designations: AM-833, AM833, NN0174-0833
CAS Number: 1415456-99-3
Molecular Formula: C₁₉₄H₃₁₂N₅₄O₅₉S₂
Molecular Weight: Approximately 4,409 g/mol
PubChem describes cagrilintide as a long-acting analogue of the peptide hormone amylin and records it as a compound under investigation.
Research Information
Cagrilintide is a synthetic peptide compound that has been investigated in research involving amylin and calcitonin-family receptor systems. Its molecular structure includes lipidation and a cyclic disulfide configuration.
This listing intentionally describes the compound according to its chemical identity and research classification.
It does not describe cagrilintide as a treatment for obesity, diabetes, weight management, or any other medical condition.
Regulatory Status
FDA currently states that cagrilintide cannot be used in compounding under federal law and that it is not a component of an FDA-approved drug and has not been found safe and effective for any condition.
FDA has also taken enforcement action concerning websites marketing cagrilintide for sale in the United States as an unapproved new drug.
For that reason, this product page should remain strictly focused on research identification and laboratory use and should not contain therapeutic claims, dosing instructions, administration instructions, or human-use recommendations.
Research Applications
Cagrilintide may be examined in controlled laboratory environments for purposes such as:
Peptide characterization
Analytical testing
Structural investigation
Molecular research
Receptor-related research
Comparative peptide studies
Laboratory assay development
Peptide pharmacology research
These descriptions refer only to potential laboratory research applications and do not constitute recommendations for administration to humans or animals.
Product Specifications
Product Name: Cagrilintide
Alternative Designation: AM-833
Product Type: Synthetic Research Peptide
Primary Category: Research Peptides
Scientific Classification: Long-Acting Amylin Analogue
CAS: 1415456-99-3
Molecular Formula: C₁₉₄H₃₁₂N₅₄O₅₉S₂
Molecular Weight: ~4,409 g/mol
Intended Application: Laboratory and scientific research
Important Product Information
Do not use “FDA approved,” “FDA cleared,” “weight-loss drug,” “GLP-1,” “obesity treatment,” or similar language to describe this research material.
Cagrilintide is a distinct peptide compound and should not be represented as semaglutide, tirzepatide, or another FDA-approved drug.
If your material is specifically supplied as cagrilintide acetate, verify the salt form against the manufacturer’s documentation before publishing the molecular specifications. PubChem maintains a separate record for cagrilintide acetate.
Product identity, peptide content, purity, salt form, analytical results, and other batch-specific specifications should be verified against the applicable Certificate of Analysis (COA).
Research Use Notice
This product is supplied solely as a research material for qualified laboratory and scientific use.
It is not intended for human consumption, human therapeutic use, veterinary use, diagnosis, treatment, mitigation, or prevention of disease.
Nothing on this product page should be interpreted as a recommendation or representation that cagrilintide is intended to affect the structure or function of the human body.
Not for use as a drug, dietary supplement, food, cosmetic, or medical treatment.
For laboratory research purposes only.
